Dipeptidyl peptidase inhibitors for the treatment of diabetes

Details Dipeptidyl peptidase inhibitors for the treatment of diabetes Dipeptidyl peptidase inhibitors for the treatment of diabetes

2006-08-29

2006-08-29

Lambkin, Deborah C. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S537000

Reexamination Certificate

active

07098239

ABSTRACT:
Compounds having Formula I, including pharmaceutically acceptable salts and prodrugs thereof: (Formula I) are inhibitors of the dipep tidyl peptidase-IV enzyme (DP-IV), and are useful in the treatment of DP-IV mediated diseases and conditions, such as non-insulin dependent diabetes mellitus.

REFERENCES:
patent: 4386090 (1983-05-01), Moinet et al.
patent: 5939560 (1999-08-01), Jenkins et al.
patent: 6903130 (2005-06-01), Lamberty et al.
patent: 6911467 (2005-06-01), Evans
patent: 6946468 (2005-09-01), Boyle et al.
patent: 7026316 (2006-04-01), Ashton et al.
patent: WO 97/40832 (1997-11-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 00/34241 (2000-06-01), None
patent: WO 01/34594 (2001-05-01), None
patent: WO 01/96295 (2001-12-01), None
patent: WO 01/96295 (2001-12-01), None
patent: WO 02/02560 (2002-01-01), None
patent: WO 02/02560 (2002-01-01), None
patent: WO 02/076450 (2002-10-01), None
patent: WO 03/000180 (2003-01-01), None
patent: WO 03/000180 (2003-01-01), None
patent: WO 03/000181 (2003-01-01), None
patent: WO 03/000181 (2003-01-01), None
patent: WO 03/004498 (2003-01-01), None
patent: WO 03/082817 (2003-10-01), None
Expert Opinion onTherapeutic Patents, “Novel N-substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidyl peptidase IV in the treatment of non-insulin-dependent diabetes mellitus”, vol. 10 (#12) p. 1937-1942 (2000).
Expert Opinion on Investig. Drugs, “Gut peptides in the treatment of diabetes mellitus”, (2004) 13 (3) 177-188.
Expert Opinion on Investig. Drugs, “Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes”, (2003) 12: 87-100.
Expert Opinion on Therapeutic Patents, “Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes”, (2003) 13: 499-510.

Affiliated with

Also associated with

Rating

Dipeptidyl peptidase inhibitors for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipeptidyl peptidase inhibitors for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase inhibitors for the treatment of diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3706603